Clinical GCT Trial Design | Regulatory | Strategy, Innovation and Future Direction | Risk vs Hype
Monday, May 2, 2022
This panel will delve into clinical trials for GCT. How do these trials differ from those for conventional therapeutics? What are the key lessons learned from completed GCT trials? How is the regulatory landscape shifting and what will that mean for the future of GCT?
- Moderator:
-
- Angela Shen, MD
-
- Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
- Panelists:
-
- Laura Aguilar, MD, PhD
-
- Co-Founder, Candel Therapeutics
- Matthew Frigault, MD
-
- Clinical Director, Cellular Immunotherapy Program, MGH
- Assistant Professor of Medicine, HMS
- Arati Rao, MD
-
- Senior Vice President, Clinical Development, PACT Pharma
- John Rossi
-
- VP Head of Translational Medicine, Syncopation Life Sciences